These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29680587)

  • 1. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
    Vos M; Plasmeijer EI; van Bemmel BC; van der Bij W; Klaver NS; Erasmus ME; de Bock GH; Verschuuren EAM; Rácz E
    J Heart Lung Transplant; 2018 Jul; 37(7):853-859. PubMed ID: 29680587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.
    Plasmeijer EI; Sachse MM; Gebhardt C; Geusau A; Bouwes Bavinck JN
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():33-37. PubMed ID: 31833604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?
    Johnson DW; Nicol DL; Purdie DM; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM
    Transplantation; 2002 Apr; 73(7):1158-63. PubMed ID: 11965051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
    Dusendang JR; Carlson E; Lee DS; Marwaha S; Madani S; Alexeeff SE; Webber A; Goes NB; Herrinton LJ
    J Am Acad Dermatol; 2022 Mar; 86(3):598-606. PubMed ID: 34384835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study.
    Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    J Am Acad Dermatol; 2016 Jun; 74(6):1144-1152.e6. PubMed ID: 26830865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases.
    van den Reek JM; van Lümig PP; Janssen M; Schers HJ; Hendriks JC; van de Kerkhof PC; Seyger MM; de Jong EM
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):27-33. PubMed ID: 23216663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
    Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
    J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.
    Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
    Transplant Proc; 2016 Apr; 48(3):969-73. PubMed ID: 27234781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
    Doesch AO; Müller S; Konstandin M; Celik S; Kristen A; Frankenstein L; Ehlermann P; Sack FU; Katus HA; Dengler TJ
    Transplant Proc; 2010 Nov; 42(9):3694-9. PubMed ID: 21094840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
    Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of mycophenolate mofetil and azathioprine dose on renal allograft outcome in the United kingdom.
    Shah S; Collett D; Johnson R; Raftery M; Rudge C; Yaqoob MM
    Transplantation; 2008 Oct; 86(8):1035-42. PubMed ID: 18946340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.
    O'Neill JO; Edwards LB; Taylor DO
    J Heart Lung Transplant; 2006 Oct; 25(10):1186-91. PubMed ID: 17045930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
    De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
    JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.
    Zuckermann A; Arizon JM; Dong G; Eisen HJ; Kobashigawa J; Lehmkuhl H; Ross H; Pelligrini C; Wang SS; Barten MJ
    Transplantation; 2011 Sep; 92(5):594-600. PubMed ID: 21862955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center.
    Kwon O; Cho JH; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 May; 45(4):1487-90. PubMed ID: 23726603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
    J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
    Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.
    Madani S; Marwaha S; Dusendang JR; Alexeeff S; Pham N; Chen EH; Han S; Herrinton LJ
    JAMA Dermatol; 2021 May; 157(5):559-565. PubMed ID: 33760003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.